BRUSSELS (Reuters) -U.S. gene sequencing company Illumina's plan to divest cancer diagnostic ... before first securing EU regulatory approval. That prompted the commission, which acts as the ...

The European Commission has approved, in accordance with the EU Mergers Regulation ("EUMR"), Illumina's plan to sell GRAIL after remedial measures requiring Illumina to terminate the completed ...

The EU regulators on Friday approved plans by U.S. genomics company Illumina (NASDAQ ... required the company to submit a divestment plan to the commission to approve the transaction.

BRUSSELS, Sept 6 (Reuters) - EU antitrust regulators plan to order ... a Reuters story in July. Illumina completed the deal in August last year ahead of EU regulatory approval, resulting in ...

But Illumina still must submit a plan to the commission for approval. In the meantime, the companies must remain separate and the commission has directed Illumina to fund Grail’s cash needs to ...

BRUSSELS, April 12 (Reuters) - U.S. gene sequencing company Illumina's plan to divest cancer diagnostic ... before first securing EU regulatory approval. That prompted the commission, which ...

BRUSSELS (Reuters) -U.S. gene sequencing company Illumina's plan to divest cancer diagnostic test maker ... before first securing EU regulatory approval. That prompted the commission, which acts as ...

BRUSSELS, April 12 (Reuters) - U.S. gene sequencing company Illumina's plan to divest cancer diagnostic test ... before first securing EU regulatory approval. That prompted the commission, which acts ...